Showing results (51-60 of 142) with videos related to

Sort By:
Pageof 15
Mycoses|April 11, 2016
A cluster of Geotrichum clavatum (Saprochaete clavata) infection in haematological patients: a first Italian report and review of literatureMaria Ilaria Del Principe, Loredana Sarmati, Mariagiovanna Cefalo, et al.
Leukemia & Lymphoma|December 17, 2009
Spontaneous apoptosis and proliferation detected by BCL-2 and CD71 proteins are important progression indicators within ZAP-70 negative chronic lymphocytic leukemiaGiovanni Del Poeta, Maria Ilaria Del Principe, Luca Maurillo, et al.
Blood Reviews|June 25, 2026
Antibacterial, antifungal and antiviral prophylaxis and vaccination strategies in adult patients with acute myeloid and promyelocytic leukemia: An expert panel consensus from the GIMEMA groupFrancesco Marchesi, Corrado Girmenia, Enrico Maria Trecarichi, et al.
Cancers|November 26, 2022
Predictors of Early Thrombotic Events in Adult Patients with Acute Myeloid Leukemia: A Real-World ExperienceGiovangiacinto Paterno, Raffaele Palmieri, Vittorio Forte, et al.
Journal of Translational Medicine|March 10, 2010
Prognostic impact of ZAP-70 expression in chronic lymphocytic leukemia: mean fluorescence intensity T/B ratio versus percentage of positive cellsFrancesca M Rossi, Maria Ilaria Del Principe, Davide Rossi, et al.
Leukemia Research and Treatment|June 6, 2013
Phase II Study of Bortezomib as a Single Agent in Patients with Previously Untreated or Relapsed/Refractory Acute Myeloid Leukemia Ineligible for Intensive TherapyChiara Sarlo, Francesco Buccisano, Luca Maurillo, et al.
American Journal of Hematology|March 31, 2012
A shorter time to the first treatment may be predicted by the absolute number of regulatory T-cells in patients with Rai stage 0 chronic lymphocytic leukemiaGiovanni D'Arena, Fiorella D'Auria, Vittorio Simeon, et al.
British Journal of Haematology|April 3, 2004
CD90/Thy-1 is preferentially expressed on blast cells of high risk acute myeloid leukaemiasFrancesco Buccisano, Francesca Maria Rossi, Adriano Venditti, et al.
European Journal of Haematology|November 22, 2007
Evaluation of the prognostic relevance of L-selectin and ICAM1 expression in myelodysplastic syndromesFrancesco Buccisano, Luca Maurillo, Anna Tamburini, et al.
Haematologica|March 17, 2022
Clinical relevance of an objective flow cytometry approach based on limit of detection and limit of quantification for measurable residual disease assessment in acute myeloid leukemia. A post-hoc analysis of the GIMEMA AML1310 trialFrancesco Buccisano, Raffaele Palmieri, Alfonso Piciocchi, et al.
Pageof 15